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When measured by ultrasound, the morphological markers of carotid atherosclero-
sis such as intima-media thickness (IMT) and cross-sectional plaque area have been
associated with the risk of ischaemic stroke. We set out to determine whether the
morphological parameters of the carotid arteries made it possible to better differen-
tiate between groups of older atherothrombotic stroke patients and persons with-
out cerebrovascular disease than conventional and novel risk factors of stroke.
Of the total number of 623 persons examined, 54 stroke patients (mean age
63.3 years) and 74 controls without cerebrovascular disease (mean age 66.3
years) fulfilled the inclusion criteria for this investigation and were enrolled in
the case-control study. After adjustment for age, gender and education level,
the strongest associations were found between stroke and carotid IMT [odds
ratio (OR) = 10.6; 95% confidence interval (CI): 4.3–26.9] and plaque area (OR
= 5.4; 95%CI: 2.3–13.1). Other risk factors showed weaker associations with
stroke occurrence. Of the clinical risk factors, a significant association was found
between stroke and coronary heart disease (OR = 3.5; 95%CI: 1.2–10.2), hy-
pertension (OR = 3.2; 95%CI: 1.5–7.2) and smoking (OR = 2.7; 95%CI: 1.1–
–6.4). From the laboratory-derived risk factors a significant association was found
between stroke and triglyceride levels (OR = 4.4; 95%CI: 1.9–10.0), and an
inverse correlation was observed between stroke occurrence and HDL-choles-
terol level (OR = 0.4; 95%CI: 0.2–0.8).
The carotid IMT and plaque area, measured with the use of ultrasonography,
showed a better correlation with stroke occurrence than currently recognised
clinical and biochemical risk factors. The intima-media thickness and plaque area
of the carotid arteries could be useful parameters in the development of strate-
gies to identify patients at high risk of atherothrombotic ischaemic stroke.
Key words: atherosclerosis, brain infarction, carotid plaques,
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INTRODUCTION
In clinical practice the physician often wishes to
identify those patients at risk of ischaemic stroke and
to decide which of them require more aggressive
medical therapy. This can be difficult, especially in
older patients, most of whom present with a variety
of risk factors of atherosclerosis. The influence of
each single risk factor on the development of carot-
id and cerebral atherosclerosis and the risk of stroke
may have changed during the patient’s lifetime.
Some of these risk factors (such as hypertension) may
have been diagnosed previously and treated for some
time, while others may have been dependent on
environmental circumstances, such as previous in-
fections with Chlamydia pneumoniae (C. pneumo-
niae). Features of the patient’s life-style such as smok-
ing, over-eating, stress and levels of physical activity
may also have changed with time. Since the physi-
cian examines the patient at a given moment in the
patient’s life, it is impossible to assess all the risk fac-
tors which may have had an influence on that patient
in the course of that life. In spite of ongoing progress
in the identification of novel risk factors such as high
plasma homocysteine and lipoprotein (a) [Lp(a)] con-
centration, C. pneumoniae infection or increasing se-
rum C-reactive protein (CRP) concentration [26], it is
possible that some risk factors are not recognised at
all. Spence et al. [29] estimated that only half the
plaques measured with the use of ultrasound can
be explained by the usual risk factors.
Under such circumstances there is an urgent need
for a simple and inexpensive test which is indepen-
dent of more or less precise knowledge of the pa-
tient’s previous and current risk factors that can help
in assessing the risk of stroke. A possible tool for the
assessment of stroke risk is high sensitivity B-mode
ultrasonography of the carotid arteries [6, 9, 21, 33].
Previous prospective studies which focused on the
relation between carotid intima-media thickness
(IMT) and ischaemic stroke were adjusted for a rela-
tively small number of conventional risk factors and
did not take into consideration the novel risk factors
[6, 21, 33]. Knowledge of the correlation between
stroke occurrence and various conventional and novel
risk factors could be helpful in the development of
strategies to identify high-risk patients and to im-
prove physicians’ decision-making processes regard-
ing the adjustment of therapeutic and preventive
methods.
We set out to determine whether morphological
carotid artery wall parameters measured by ultra-
sound, such as IMT or cross-sectional plaque area,
allow better differentiation between older athero-
thrombotic stroke patients and age and gender
matched persons without cerebrovascular disease
than is afforded by other conventional and novel
atherosclerosis risk factors.
MATERIAL AND METHODS
Sample
Of the total of 623 persons who attended the
Laboratory for Cerebrovascular Research of our De-
partment of Neurology during the period from Jan-
uary 2001 to June 2002, 54 patients with athero-
thrombotic stroke (including 29 males) fulfilled the
inclusion criteria of the study. The stroke patients
were referred by their physicians for the assessment
of atherosclerosis of their carotid and vertebral ar-
teries. The mean interval between stroke and partic-
ipation in the study was 4.2 ± 2.2 years.
The control group consisted of 74 persons (includ-
ing 36 males) without cerebrovascular disease who
attended a local club for senior citizens drawn from
a variety of backgrounds. The controls were recruited
from members of the club in the same proportion
with regard to educational background as the stroke
patients. The level of education of the patients and
controls was self-reported during the demographic
interview and classified for the purpose of this study
by years of education, i.e. Group 1: ≥ 15 years, Group 2:
11–14 years, Group 3: £ 10 years.
There were 17 (31.5%) stroke patients as com-
pared to 23 (31.1%) controls in the first educational
group and 26 (48.1%) stroke patients to 36 (48.6%)
controls and 11 (20.4%) stroke patients to 15 (20.3%)
controls in the second and third groups respective-
ly. The differences in education between the groups
were not statistically significant. The mean age of
all the subjects was 65.0 ± 7.9 years, 63.3 ± 7.2 for
the stroke patients, and 66.3 ± 8.5 for the controls.
Exclusion criteria
The exclusion criteria took account of the fact
that it has recently been demonstrated that one-year
treatment with statins is sufficient to induce IMT
regression [31] and also that C. pneumoniae-posi-
tive patients treated with macrolid antibiotics show
reduced progression of carotid atherosclerosis [27].
In the present study, therefore, we excluded patients
treated with these drugs.
Recent infectious disease, brain infarction and
myocardial infarction (MI) are related to increased
leukocyte counts, plasma fibrinogen levels and CRP
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serum levels [4, 28, 36]. Subjects who had experi-
enced any infectious disease within 6 months and
a stroke or MI within 12 months prior to the com-
mencement of the study were not included. Those
who had undergone carotid surgery or angioplasty
were also excluded from the study. The study only
concerned patients with atherothrombotic stroke
and so did not include patients for whom full hospi-
tal records, including those for head-computed to-
mography (CT) or magnetic resonance imaging (MRI),
were not available. We did not include patients with
cardiac sources of cerebral embolism such as atrial
fibrillation, mitral stenosis or a mechanical prosthetic
valve or those in whom ultrasound examination re-
vealed a hipokinetic left ventricular segment or a left
ventricular thrombus. Patients with a lacunar stroke
diagnosed by CT or MRI were also excluded as were
patients with a suspected stroke of other or unde-
termined etiology.
Inclusion criteria
The TOAST ischaemic stroke classification system
was used in the study [2]. Only the stroke patients
who fulfilled the TOAST criteria for thrombo-embo-
lic stroke (“large-artery stroke”) were included in the
study.
Ultrasonography
Carotid IMTs were assessed using high-resolution
ultrasound (Sonoline Sienna, Siemens with 7.5 MHz
probe). All the subjects were examined in the supine
position by the same sonographer (R.K.). The left and
right arteries were scanned by a longitudinal ultra-
sound image of the far walls of the arteries in both
the antero-posterior and lateral planes.
The carotid IMTs were assessed, by the same
sonographer (R.K.), as previously described [17]. In
brief, for the purpose of the evaluation, the carotid
artery was divided into 3 segments based on arterial
anatomy. The first segment included the distal 2-cm
of the vascular wall of the common carotid artery
(CCA) immediately proximal to the dilatation of the
bifurcation. The second segment, the carotid bulbs
(BULB), was defined as the segment between the ca-
rotid dilatation and the flow divider of the internal
and external carotid arteries. The third segment, the
internal carotid artery (ICA), was defined as the seg-
ment immediately distal to the tip of the flow divider
over a 1 cm distance. The loss of the parallel wall con-
figuration, which marks the origin of the bulb seg-
ments, was easily identified as a consistent marker of
the distal end of the CCA segment (Fig. 1).
Plaque was defined as a local thickening of the
intima and media protruding into the lumen, with
a thickness exceeding 100% of the mean IMT of the
segment in a given plane.
The cross-sectional area of the plaque was as-
sessed, by the same sonographer (R.K.), as de-
scribed by Spence et al. [30]. In brief, the plane in
which the measurement of each plaque was made
was chosen by panning around the artery until the
view showing the largest extent of that plaque was
obtained. To shorten the time of ultrasound ex-
amination of each patient the images were frozen
and stored on 3.5 inch diskettes for off-line analy-
sis. Afterwards, each plaque cross-sectional area
was measured off-line by tracing around the pe-
rimeter with a cursor on the scanner screen. The
cross-sectional area of the plaque was assessed
with the use of the scanner’s software [30]. If there
were two or more plaques in the same artery the
sum of all the cross-sectional areas of all the
plaques seen in the carotid artery was taken as
the total plaque area. Additionally, the Duplex
colour mode was used to ensure that no hypo-
echogenic (echolucent) plaques were missed in the
region examined.
The reproducibility of the measurement of IMT,
evaluated according to the Bland-Altman method,
has been described elsewhere [17].
The reproducibility of the measurement of the
carotid plaque cross-sectional area was also evalu-
ated according to the Bland-Altman method [5]. The
mean intraobserver difference between double mea-
surements performed on a sample of 20 patients was
0.18 mm2 (95%CI: –7.94–8.30).
Figure 1. A. High-resolution ultrasound longitudinal image of the
distal common carotid artery (CCA), the bulb (bifurcation), the
proximal internal (ICA) and external (ECA) carotid arteries as de-
fined by the study protocol; B. The arrows indicate intima-media
thickness on the far wall of the carotid artery segments.
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Clinical evaluation
A standardised questionnaire to provide informa-
tion about demographic background, occupation,
education and medical history was completed at each
examination. Blood pressure measurements were
taken twice, at the beginning and end of the study
session, after 10 minutes rest in the sitting position.
Subjects were considered hypertensive if they had,
on both measurements, systolic blood pressure
≥ 140 mmHg or a diastolic blood pressure ≥ 90 mm
Hg, or if they were taking antihypertensive medica-
tions. Subjects were defined as diabetic if the fast-
ing glucose level was ≥ 7.00 mmol/L (126 mg/dl) or
if they were taking antidiabetic medications. They
were classified as smokers if they smoked at least
1 cigarette per day; as non-smokers if they had nev-
er smoked or as ex-smokers if they had given up
smoking > 1 year previously (for the purpose of this
study we pooled the current and ex-smokers). Stroke,
coronary heart disease (CHD) and myocardial infarc-
tion was diagnosed on the basis of the history and
the patient’s hospital and out-patient records.
The body mass index (BMI) was calculated for
each subject. Blood was drawn once, after 12 hours
of fasting. Serum lipoproteins were measured using
standard enzymatic methods (Synchron CX 7 analy-
ser, Beckman, USA) and LDL cholesterol (LDL-C) was
calculated by the Friedewald formula [13]. Serum
glucose was assessed with the use of an EBIOBASIC
glucose analyser (Eppendorf, Germany). The leuko-
cyte count was measured by an automated method
(Sysmex K4500, USA) and the fibrinogen plasma
concentration was assessed by nephelometry
(Nephelometer ACL 100, IL, USA). The plasma con-
centrations of homocysteine, methionine and cys-
teine were measured with the use of high-perfor-
mance liquid chromatography (Gynkotek, Germany)
with an electrochemical detector (CoulArray 5600,
ESA, USA), as described elsewhere [1].
CRP and Lp(a) serum concentrations were measured
with a high-sensitive immunoassay and determinations
were performed with the Behring Nephelometer BN II
(Dade Behring, Germany), according to the method
described elsewhere [19, 23]. Levels of C. pneumoni-
ae-specific IgG and IgA serum antibodies were deter-
mined by enzyme immunoassay with a major outer
membrane protein complex as diagnostic antigen
(ELEGANCE C. pneumoniae IgG & IgA ELISAs, Bioclone,
Australia). Concentrations of chlamydial antibodies
were expressed as the index (optical density of the sam-
ple/cut-off value). The tests were carried out according
to the manufacturer’s instructions.
Written informed consent for blood sampling and
ultrasound examination for research purposes was
obtained from each person included in the study and
the study protocol was approved by the Medical
School Ethics Committee.
Statistical analysis
Data are given as mean ± SD, and for non-nor-
mal measurements (the Shapiro-Wilks W test) as the
geometric mean and 1 SD range ( Gx ; ± 1SD). For
data showing no departures from normality (accord-
ing to the Shapiro-Wilks test) we used the standard
unpaired Student t test. The Mann-Whitney U test
was employed for the remaining variables to assess
the significance of differences between groups. Dis-
crete variables were compared with the use of the
test for proportions.
For odds ratio analysis the Mantel-Haenszel Chi-
-square test we used the opposed values of dichot-
omised continuous variables from below median
range (< Me, rank 0) and above median range
(≥ Me, rank 1) or from the 1st (rank 0) and 4th
(rank 1) quartiles. The values of the clinical param-
eters were ranked on the basis of the presence or
absence of a given character.
The statistical analyses were made with Statisti-
ca version 5.5 (StatSoft, Inc. 2000) and StatsDirect
(StatsDirect Ltd. 2000) software.
RESULTS
The morphological parameters for the carotid
arteries, as well as the baseline clinical characteris-
tics and biochemical results for the two groups un-
der investigation, are presented in Table 1.
No patients with de novo recognised diabetes or
hypertension were found in this study and all the
patients with these conditions had been treated pri-
or to entry to the study. To avoid statistical bias we
did not include diabetes in the analysis, as only one
patient from the control group and 11 stroke pa-
tients suffered from diabetes.
The ultrasonographically-measured morphologi-
cal parameters of the carotid arteries such as IMT and
mean plaque area demonstrated the most significant
differences between subjects with and without stroke.
Plaque occurrence was significantly different be-
tween two groups investigated (Table 1). Of the 128
persons, 71 had measurable carotid plaque. There
were 44 out of 71 patients (62%) with plaques in
the carotid bulbs, and 27 out of 71 patients (38%)
with plaques in the internal carotid arteries. In the
common carotid arteries the plaques were visible in
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10 patients, all of whom also had plaques in the
carotid bulb.
The odds ratios for the carotid artery morpho-
logical parameters and the clinical or biochemical
risk factors for stroke, according to the median of
the parameters assessed, are shown in Figure 2.
Total IMT and plaque area dichotomised accord-
ing to quartiles showed more significant correlation
than those dichotomised according to the median
(OR = 46.0; 95%CI: 8.0–442.4, p < 0.0001 and OR
= 12.9; 95%CI: 4.0–43.0, p < 0.0001, respectively).
Hypertension, CHD, smoking and triglycerides
were the most significant conventional risk factors
derived from both clinical evaluation and laboratory
examinations. An inverse correlation between stroke
occurrence and HDL cholesterol (HDL-C) was also
found to be significant.
Table 1. Baseline carotid IMT, clinical and biochemical characteristics in stroke patients and controls
Variables Stroke patients (n = 54) Controls (n = 74) p
IMT total [mm] 1.11 ± 0.39 0.74 ± 0.26 < 0.0001
IMT CCA [mm] 0.87 ± 0.29  0.64 ± 0.17 < 0.0001
IMT bulb [mm] 1.36 ± 0.52 0.88 ± 0.46 < 0.0001
IMT ICA [mm] 0.93 ± 1.11  0.54 ± 0.71 < 0.0001
Plaque occurrence 42 (78%) 29 (39%) < 0.0001
Plaque area [mm2] 36 (16–74) 14 (6–25) < 0.0001
Total cholesterol [mg/dL] 231 ± 40 230 ± 47 0.958
HDL cholesterol* [mg/dL] 45 ± 12 50 ± 13 0.028
LDL cholesterol [mg/dL] 155 ± 34 152 ± 30 0.967
Triglycerides [mg/dL] 134 ± 48 119 ± 82 0.0005
Lipoprotein (a) [mg/L] 0.10 ± 0.15 0.11 ± 0.21 0.788
Cysteine* [µmol/L] 274 ± 93 282 ± 87 0.311
Homocysteine [µmol/L] 18.3 ± 7.9 15.8 ± 11.1 0.022
Methionine [µmol/L] 21.1 ± 6.7 22.5 ± 10.8 0.188
C. pneumoniae IgG, antibody index 1.44 ± 1.40 1.19 ± 1.01 0.220
C. pneumoniae IgA, antibody index 0.93 ± 0.77 1.02 ± 0.95 0.430
Fibrinogen* [g/L] 4.22 ± 0.86 4.02 ± 0.90 0.237
C-reactive protein [mg/L] 2.86 ± 5.18 1.87 ± 6.51  0.029
Leukocyte count [× 109/L] 7.19 ± 2.34  5.58 ± 1.83 0.001
Body mass index* [kg/m2] 26.2 ± 3.6 25.7 ± 3.1 0.179
Smoking 34 (63%) 25 (34%) < 0.0001
Hypertension 32 (59%) 23 (31%) 0.001
Coronary heart disease 19 (35%)  8 (11%)  0.0008
*Variables not showing departures from normal distribution are presented as arithmetic means (±SD) and tested with the Student t unpaired test. The remaining continu-
ous variables are shown as geometric means (±SD) and were tested with the Mann-Whitney U test. Plaque area data presented as median and quartile ranges. Discrete
variables compared with the use of z test for proportions. All data were standardised for age and data showing differences between sexes were also standardised for sex.
Data for plasma fibrinogen and leukocyte count were additionally standardised to smoking.
No significant correlation was found between
stroke and the other parameters, including BMI, to-
tal cholesterol (total-C), LDL-C, fibrinogen, Lp(a) and
C. pneumoniae IgG or IgA antibody indices. Ho-
mocysteine and CRP plasma levels were significantly
different in the two groups (Table 1), while a signif-
icant association with stroke was reached for ho-
mocysteine only when dichotomised according to
quartiles (OR = 4.8; 95%CI: 1.4–16.7, p = 0.0086),
although this association was not significant accord-
ing to the median (Fig. 2).
DISCUSSION
The results of the present study have demonstrat-
ed that the morphological parameters of the carot-
id arteries measured by ultrasound, such as total IMT
and cross-sectional plaque area, show much better
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associations with stroke occurrence than the other
risk factors assessed in the study. We also found that
IMT, measured separately in the bulb, common ca-
rotid artery (CCA) or internal carotid artery (ICA), also
differs significantly in the two groups assessed. The
overall cross-sectional area of plaques was also found
to be a sensitive marker of stroke risk. Such a result
could be expected, since atherosclerosis of the ca-
rotid arteries is one of the most important causes of
ischaemic stroke among older persons [3, 6]. The
strong correlation between carotid IMT, plaque area
and the risk of stroke in older adults has been re-
ported in large prospective studies [6, 20, 21, 30,
33]. Furthermore, carotid IMT is regarded as a reli-
able marker of generalised atherosclerosis [14].
With regard to variables concerning the bio-
chemical risk factors such as triglyceride or ho-
mocysteine levels, the association with stroke risk
was in line with previous reports [10, 15, 18, 32].
Other plasma thiol compounds, such as cysteine and
methionine, have not been shown to be associated
with stroke or carotid atherosclerosis [10]. Inter-
estingly, in the present study no correlation was
found between total-C and LDL-C and risk of stroke.
Large reviews of cohort studies previously under-
taken have shown no correlation between any type
of stroke and total cholesterol levels in persons aged
over 45 [22]. On the other hand, an association was
found between the total-C serum level and non-
haemorrhagic stroke in men aged 35 to 57 years
[15]. It is believed however, that lipids are general-
ly a weaker stroke risk factor among older persons
[35]. There is evidence that total-C and LDL-C de-
creases with age in both men and women [11]. The
decline of HDL-C is far more modest, and the total-
C/HDL-C ratio increases with age, especially in men
[16]. It does not seem surprising that no associa-
tion between a history of stroke and serum LDL-C
and total-C was found in the population examined
here, which had a mean age of 65 years, while
a negative correlation between HDL-C and stroke
occurrence was found. The basal state of HDL-C has
been demonstrated to possess anti-inflammatory
properties [34], HDL-C mediates the efflux of cho-
lesterol from lipid-loaded cells [24] and a low HDL-
C level has been positively associated with carotid
atherosclerosis and stroke risk [32].
Since it has been demonstrated that atheroscle-
rosis is a low-grade inflammatory process, inflam-
matory markers such as CRP may provide a useful
adjunctive method for the global assessment of ath-
erosclerosis risk factors [7, 25]. Some pathomecha-
nism mediated by CRP may additionally augment
atherogenesis or thrombus formation in the cere-
bral arteries [7, 8, 12].
In the present study CRP levels differed signifi-
cantly between stroke patients and controls when
compared with the Mann-Whitney U test, although
Figure 2. Cochrane odds ratio plot for carotid IMT, carotid plaques and biochemical parameters as risk factors for stroke dichotomised ac-
cording to median. Fixed effect Mantel-Haenszel Chi-square test of odds ratios was calculated based on conditional maximum likelihood
(OR = 2.427; 95%CI: 1.928–3.057). Opposed values of dichotomised continuous variables are from below median range (< Me, rank 0) and
above median range (≥ Me, rank 1). OR values presented on a logarithmic scale; 95%CI of OR are displayed as boxes (for a given parame-
ter) or a white diamond (for all pooled parameters) with a central vertical line denoting the odds ratio itself.
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no significant differences between the groups were
evidenced in the frequencies of the higher CRP val-
ues according to the estimates of the Mantel-Haen-
szel odds ratio.
Limitations of the study
The obvious limitation of this study was the rela-
tively small number of subjects and its cross-sectional
design. This design was deliberately “broad” (a large
battery of tests and a larger number of variables)
rather than “deep” (a relatively small population).
This was because the aim was to detect trends and
associations within a wide range of risk factors that
could have a relationship with stroke risk.
The cross-sectional design of the study was as
close as possible to the real situation of the consult-
ant in the out-patients department who has to make
a therapeutic decision based on the facts which he
or she has ascertained at the time of consultation.
CONCLUSIONS
The morphological markers of carotid artery ath-
erosclerosis such as IMT in different segments of the
artery and carotid plaque area, when measured with
the use of ultrasonography, were demonstrated as
significantly larger in the atherothrombotic stroke
patients than in the controls without cerebrovascu-
lar disease. Clinically-derived risk factors and those
assessed in laboratory examination showed, to a less-
er extent, the differences between stroke patients
and those without cerebrovascular disease, and
hence seem less significant in this multi-parametric
analysis.
Overall, B-mode high-sensitive carotid ultrasonog-
raphy appears to be a useful diagnostic tool for dif-
ferentiating between stroke patients and controls
with a mean age of 65 years. The carotid IMT and
plaque area measured by ultrasonography meets
some of the requirements for an ideal method for
the identification of subjects with a high likelihood
of developing stroke, since the method is relatively
inexpensive, non-invasive, reproducible and readily
applicable to an asymptomatic population [20]. Ca-
rotid IMT and plaque area could also be helpful in
assessing the efficacy of preventive therapy, espe-
cially at present, when only approximately half the
existing atherosclerotic risk factors can be identified.
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